Survey Finds Customers Take Multiple Supplements for Energy
August 13, 2024 10:15 ET
|
Life Extension
Fort Lauderdale, FL, Aug. 13, 2024 (GLOBE NEWSWIRE) -- We need energy to get through our day, but it’s common for levels to fizzle out as the hours pile on. A recent survey of over 3,000 Life...
Protein Is More Than Just Muscle Food: Achieve Your Protein Goals with Tracking
August 13, 2024 09:57 ET
|
D S Simon
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Did you know protein can do more than build muscles? Recently, Melissa Jaeger, RD, LD, Head of Nutrition at MyFitnessPal, conducted a satellite media tour...
DANDY® CELERY OFFERS HYDRATION SOLUTION FOR PEAK SUMMER DAYS
August 13, 2024 09:47 ET
|
Duda Farm Fresh Foods
Oviedo, Fla., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Dandy® Produce, a leading grower of fresh celery, radish and corn in the U.S., elevates the hydration benefits of celery and celery juice for the...
For a Sixth Time, Priority OnDemand Makes the Inc. 5000 of Fastest Growing Private Companies
August 13, 2024 09:05 ET
|
Priority OnDemand
New York, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Inc. revealed today that Priority OnDemand ranks No. 4573 on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The...
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
August 13, 2024 09:00 ET
|
NeurAxis, Inc.
CARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...
RTLS for Healthcare Market Share Will Reach Over USD 17.16 Billion by 2034, at 19.8% CAGR: Prophecy Market Insights
August 13, 2024 08:24 ET
|
PMI
Covina, Aug. 13, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights, the global RTLS for healthcare market size and share is projected to grow from USD 3.3 Billion in 2024 and is...
NGS-Based RNA-Sequencing Market Size Worth Over USD 11.1 Billion by 2034 | CAGR of 18.10%: Prophecy Market Insights
August 13, 2024 08:06 ET
|
PMI
Covina, Aug. 13, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights, the global NGS-based RNA-sequencing market size and share is projected to grow from USD 2.1 Billion in 2024 and is...
Noema Pharma Announces Completion of Enrollment for GALENE Phase 2B Trial Evaluating NOE-101, a First-in-Class mGluR5 NAM, for Seizure Control in Tuberous Sclerosis Complex
August 13, 2024 08:00 ET
|
Noema Pharma AG
-- Top-line results from Phase 2B study expected in first quarter of 2025 -- BASEL, Switzerland, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Noema Pharma AG, a clinical-stage biotech company targeting...
Biomed Valley Discoveries Announces First Patient Dosed in Phase 2 Study of Its First-in-Class ERK 1/2 Inhibitor Ulixertinib in People with Histiocytosis
August 13, 2024 08:00 ET
|
Biomed Valley Discoveries, Inc.
Biomed Valley Discoveries today announced that the first patient has been dosed in a Phase 2 study of ulixertinib for the treatment of histiocytosis.
Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
August 13, 2024 08:00 ET
|
Daré Bioscience, Inc.
Published data show that responses from 1-month and 24-hour recall patient reported outcome (PRO) instruments were similar and support that either method could be used to assess treatment efficacy in...